Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Ischemic Heart Disease

Free Subscription Articles published in J Thromb Haemost Retrieve available abstracts of 6 articles: HTML format Text format

Single Articles

May 2019
1. SMABREKKE B, Rinde LB, Evensen LH, Morelli VM, et al
   Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
   J Thromb Haemost. 2019 May 24. doi: 10.1111/jth.14493.
   PubMed     Text format     Abstract available
   
   
   August 2018
2. SCHOOLING CM, Luo S, Johnson G
   ADAMTS-13 activity and ischemic heart disease: A Mendelian randomization study.
   J Thromb Haemost. 2018 Aug 12. doi: 10.1111/jth.14267.
   PubMed     Text format     Abstract available
   
   
   July 2018
3. OCAK G, Noordzij M, Rookmaaker MB, Cases A, et al
   Mortality due to bleeding, myocardial infarction and stroke in dialysis patients.
   J Thromb Haemost. 2018 Jul 31. doi: 10.1111/jth.14254.
   PubMed     Text format     Abstract available
   
   
   February 2018
4. BEIGEL R, Mazin I, Koifman E, Shechter M, et al
   Aspirin Withdrawal in Patients Treated with Ticagrelor Presenting with Non-ST Elevation Myocardial Infarction.
   J Thromb Haemost. 2018 Feb 14. doi: 10.1111/jth.13977.
   PubMed     Text format     Abstract available
   
   
   April 2017
5. LANNAN KL, Spinelli SL, Blumberg N, Phipps RP, et al
   Maresin 1 induces a novel pro-resolving phenotype in human platelets.
   J Thromb Haemost. 2017;15:802-813.
   PubMed     Text format     Abstract available
   
   
   March 2017
6. ACHILLES A, Mohring A, Dannenberg L, Grandoch M, et al
   Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation.
   J Thromb Haemost. 2017;15:473-476.
   PubMed     Text format     Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: